Ensign Peak Advisors’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.89M	Buy	71,781 +15,231	+27%	+$570K	0.01%	640
2025 Q4	$1.97M	Sell	56,550 -16,864	-23%	-$1.32M	﹤0.01%	703
2025 Q3	$6.1M	Sell	73,414 -13,805	-16%	-$999K	0.01%	557
2025 Q2	$6.4M	Buy	87,219 +19,786	+29%	+$1.43M	0.01%	585
2025 Q1	$7.7M	Buy	67,433 +19,504	+41%	+$1.19M	0.01%	531
2024 Q4	$2.42M	Buy	47,929 +11,040	+30%	+$578K	﹤0.01%	862
2024 Q3	$1.71M	Hold	36,889	–	–	﹤0.01%	1019
2024 Q2	$1.2M	Hold	36,889	–	–	﹤0.01%	1168
2024 Q1	$929K	Sell	36,889 -1,861	-5%	-$44K	﹤0.01%	1377
2023 Q4	$1.26M	Hold	38,750	–	–	﹤0.01%	1204
2023 Q3	$1.06M	Hold	38,750	–	–	﹤0.01%	1160
2023 Q2	$862K	Hold	38,750	–	–	﹤0.01%	1380
2023 Q1	$839K	Buy	38,750 +1,250	+3%	+$27.4K	﹤0.01%	1390
2022 Q4	$762K	Buy	37,500 +9,500	+34%	+$238K	﹤0.01%	1389
2022 Q3	$718K	Sell	28,000 -10,750	-28%	-$288K	﹤0.01%	1261
2022 Q2	$921K	Hold	38,750	–	–	﹤0.01%	1150
2022 Q1	$873K	Hold	38,750	–	–	﹤0.01%	1282
2021 Q4	$767K	Sell	38,750 -48,650	-56%	-$987K	﹤0.01%	1412
2021 Q3	$1.72M	Hold	87,400	–	–	﹤0.01%	1207
2021 Q2	$1.92M	Buy	87,400 +1,800	+2%	+$40.1K	﹤0.01%	1153
2021 Q1	$2.04M	Buy	85,600 +33,300	+64%	+$889K	﹤0.01%	1105
2020 Q4	$1.37M	Buy	52,300 +17,800	+52%	+$375K	﹤0.01%	1261
2020 Q3	$600K	Hold	34,500	–	–	﹤0.01%	1482
2020 Q2	$580K	Hold	34,500	–	–	﹤0.01%	1431
2020 Q1	$410K	Buy	+34,500	New	+$427K	﹤0.01%	1433